Clinical impact of genomic testing in patients with suspected monogenic kidney disease
Kushani Jayasinghe(Monash Medical Centre), Catherine Quinlan(Royal Children's Hospital), Sebastian Lunke(Royal Children's Hospital), Kirsty West(The Royal Melbourne Hospital), Ella Wilkins(Victorian Clinical Genetics Services), Andrew Talbot(Melbourne Health), Elizabeth Donaldson(The Royal Melbourne Hospital), Emily See(The University of Melbourne), Alison H. Trainer(The Royal Melbourne Hospital), Giulia Valente(Austin Health), Clara Gaff(The University of Melbourne), Rigan Tytherleigh(Murdoch Children's Research Institute), John Whitlam(Austin Health), Melissa Martyn(The University of Melbourne), Belinda Creighton(Peter MacCallum Cancer Centre), Chirag Patel(Royal Brisbane and Women's Hospital), Elly Lynch(Melbourne Genomics Health Alliance), Kathy Nicholls(Melbourne Health), Jessica Ryan(Monash Medical Centre), Susan M. White(The University of Melbourne), Zornitza Stark(Zoos Victoria), Matthew F. Hunter(The University of Sydney), Yael Prawer(Monash Children’s Hospital), Louise Wardrop(Murdoch Children's Research Institute), Emma Krzesinski(The University of Melbourne), Mathew Wallis(University of Tasmania), Peter G. Kerr(Monash Health), Andrew Mallett(The University of Queensland), Lilian Johnstone, Anna Jarmolowicz(Victorian Clinical Genetics Services)
Cited by 125
Related Papers
Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases
|npj Genomic Medicine|2018|637
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
Osteopetrosis
|Orphanet Journal of Rare Diseases|2009|454
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders
|Genetics in Medicine|2016|411
Integrating Genomics into Healthcare: A Global Responsibility
|The American Journal of Human Genetics|2019|390